Adami S, Idolazzi L, Fracassi E, Gatti D, Rossini M (2013) Osteoporosis treatment: when to discontinue and when to re-start. Bone Res 1(4):323–335. https://doi.org/10.4248/BR201304003

Article  PubMed  PubMed Central  Google Scholar 

Aghaloo TL, Felsenfeld AL, Tetradis S (2010) Osteonecrosis of the jaw in a patient on Denosumab. J Oral Maxillofac Surg 68(5):959–963. https://doi.org/10.1016/j.joms.2009.10.010

Article  PubMed  PubMed Central  Google Scholar 

Aghaloo TL, Kang B, Sung EC, Shoff M, Ronconi M, Gotcher JE, Tetradis S (2011) Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat. J Bone Min Res. 26(8):1871–82. https://doi.org/10.1002/jbmr.379

Article  CAS  Google Scholar 

Aghaloo T, Hazboun R, Tetradis S (2015) Pathophysiology of osteonecrosis of the jaws. Oral Maxillofac Surg Clin North Am 27:489. https://doi.org/10.1016/j.coms.2015.06.001

Article  PubMed  PubMed Central  Google Scholar 

Aimetti M, Perotto S, Castiglione A, Mariani GM, Ferrarotti F, Romano F (2015) Prevalence of periodontitis in an adult population from an urban area in North Italy: findings from a cross-sectional population-based epidemiological survey. J Clin Periodontol 42(7):622–631. https://doi.org/10.1111/jcpe.12420

Article  PubMed  Google Scholar 

Amgen Inc. (2020) Prolia (denosumab): investigator’s brochure. Amgen Inc., Thousand Oaks

Anastasilakis AD, Pepe J, Napoli N, Palermo A, Magopoulos C, Khan AA, Zillikens MC, Body JJ (2022) Osteonecrosis of the jaw and antiresorptive agents in benign and malignant diseases: a critical review organized by the ECTS. J Clin Endocrinol Metab. 107(5):1441–1460. https://doi.org/10.1210/clinem/dgab888

Article  PubMed  Google Scholar 

Bashutski JD, Eber RM, Kinney JS, Benavides E, Maitra S, Braun TM, Giannobile WV, McCauley LK (2010) Teriparatide and osseous regeneration in the oral cavity. N Engl J Med 363:2396–2405. https://doi.org/10.1056/NEJMoa1005361

Article  CAS  PubMed  PubMed Central  Google Scholar 

Black DM, Rosen CJ (2016) Clinical practice postmenopausal osteoporosis. New Engl J Med. 374(3):254–62. https://doi.org/10.1056/NEJMcp1513724

Bodem JP, Kargus S, Eckstein S, Saure D, Engel M, Hoffmann J, Freudlsperger C (2015) Incidence of bisphosphonate-related osteonecrosis of the jaw in high-risk patients undergoing surgical tooth extraction. J Cranio-Maxillofac Surg 43(4):510–514. https://doi.org/10.1016/j.jcms.2015.02.018

Article  Google Scholar 

Cabras M, Gambino A, Broccoletti R, Sciascia S, Arduino PG (2021) Lack of evidence in reducing risk of MRONJ after teeth extractions with systemic antibiotics. J Oral Sci 63(3):217–226. https://doi.org/10.2334/josnusd.21-0016

Article  CAS  PubMed  Google Scholar 

Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, Watts NB (2020) American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis—2020 Update. Endocr Pract 26:1–46. https://doi.org/10.4158/GL-2020-0524SUPPL

Article  PubMed  Google Scholar 

Campisi G, Bedogni A, Fusco V (2020) Raccomandazioni clinico-terapeutiche sull’osteonecrosi delle ossa mascellari (ONJ) farmaco-relata e sua prevenzione, 2nd edn. Palermo University Press, Palermo

Google Scholar 

Campisi G, Mauceri R, Bertoldo F, Fusco V, Bedogni A (2021) A pragmatic window of opportunity to minimise the risk of MRONJ development in individuals with osteoporosis on Denosumab therapy: a hypothesis. Head Face Med 17(1):25. https://doi.org/10.1186/s13005-021-00280-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Campisi G, Mauceri R, Bertoldo F, Bettini G, Biasotto M, Colella G, Consolo U, Di Fede O, Favia G, Fusco V, Gabriele M, Lo Casto A, Lo Muzio L, Marcianò A, Mascitti M, Meleti M, Mignogna MD, Oteri G, Panzarella V, Romeo U, Santarelli A, Vescovi P, Marchetti C, Bedogni A (2020) Medication-related osteonecrosis of jaws (MRONJ) prevention and diagnosis: Italian consensus update 2020. Int J Environ Res Public Health 17(16):5998. https://doi.org/10.3390/ijerph17165998

Castillo EJ, Messer JG, Abraham AM, Jiron JM, Alekseyenko AV, Israel R, Aguirre JI (2021) Preventing or controlling periodontitis reduces the occurrence of osteonecrosis of the jaw (ONJ) in rice rats (Oryzomys Palustris). Bone 145:115866. https://doi.org/10.1016/j.bone.2021.115866

Article  CAS  PubMed  PubMed Central  Google Scholar 

Center JR, Lyles KW, Bliuc D (2020) Bisphosphonates and lifespan. Bone 141:115566. https://doi.org/10.1016/j.bone.2020.115566

Chapple ILC, Bouchard P, Cagetti MG, Campus G, Carra M-C, Cocco F, Schulte AG (2017) Interaction of lifestyle, behaviour or systemic diseases with dental caries and periodontal diseases: consensus report of group 2 of the Joint EFP/ORCA Workshop on the Boundaries Between Caries and Periodontal Diseases. J Clin Periodontol. 44:S39-51. https://doi.org/10.1111/jcpe.12685

Chapple ILC, Van der Weijden F, Doerfer C, Herrera D, Shapira L, Polak D, Graziani F (2015) Primary prevention of periodontitis: managing gingivitis. J Clin Periodontol. 42:S71-76. https://doi.org/10.1111/jcpe.12366

Article  PubMed  Google Scholar 

Chavassieux P, Chapurlat R, Portero-Muzy N, Roux J-P, Garcia P, Grauer JP, Brown A (2019) Bone-forming and antiresorptive effects of Romosozumab in postmenopausal women with osteoporosis: bone histomorphometry and microcomputed tomography analysis after 2 and 12 months of treatment. J Bone Min Res. 34(9):1597–1608. https://doi.org/10.1002/jbmr.3735

Article  CAS  Google Scholar 

Chen MX, Zhong YJ, Dong QQ, Wong HM, Wen YF (2021) Global, regional, and national burden of severe periodontitis, 1990–2019: an Analysis of the Global Burden of Disease Study 2019. J Clin Periodontol 48(9):1165–1188. https://doi.org/10.1111/jcpe.13506

Cummings SR, Ferrari S, Eastell R, Gilchrist N, Jensen JEB, McClung M et al (2018) Vertebral fractures after discontinuation of Denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension. J Bone Miner Res 33(2):190–198. https://doi.org/10.1002/jbmr.3337

Article  CAS  PubMed  Google Scholar 

D’Aiuto F, Parkar M, Andreou G, Suvan J, Brett PM, Ready D, Tonetti MS (2004) Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 83(2):156–160. https://doi.org/10.1177/154405910408300214

Article  PubMed  Google Scholar 

Dicembrini I, Serni L, Monami M, Caliri M, Barbato L, Cairo F, Mannucci E (2020) Type 1 diabetes and periodontitis: prevalence and periodontal destruction—a systematic review. Acta Diabetol 57(12):1405–1412. https://doi.org/10.1007/s00592-020-01531-7

Ebetino FH, Sun S, Cherian P, Roshandel S, Neighbors JD, Hu E, Russell RGG (2022) Bisphosphonates: the role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use. Bone 156:116289. https://doi.org/10.1016/j.bone.2021.116289

Article  CAS  PubMed  Google Scholar 

Eke PI, Borgnakke WS, Genco RJ (2020) Recent epidemiologic trends in periodontitis in the USA. Periodontology 2000 82(1):257–67. https://doi.org/10.1111/prd.12323

Article  PubMed  Google Scholar 

Ferrari S, Reginster J-Y, Brandi ML, Kanis JA, Devogelaer J-P, Kaufman J-M, Rizzoli R (2016) Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture. Arch Osteoporos. 11(1):37. https://doi.org/10.1007/s11657-016-0292-1

Article  PubMed  PubMed Central  Google Scholar 

Fujieda Y, Doi M, Asaka T, Ota M, Hisada R, Ohnishi N, Kono M, Kameda H, Nakazawa D, Kato M et al (2020) Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease. J Bone Miner Metab 38:1–8. https://doi.org/10.1007/s00774-020-01089-y

Article  Google Scholar 

Everts-Graber J, Lehmann D, Burkard JP, Schaller B, Gahl B, Häuselmann H, Studer U, Ziswiler HR, Reichenbach S, Lehmann T (2022) Risk of osteonecrosis of the jaw under Denosumab compared to bisphosphonates in patients with osteoporosis. J Bone Miner Res. 37(2):340–348. https://doi.org/10.1002/jbmr.4472

Article  CAS  PubMed  Google Scholar 

Gaudin E, Seidel L, Bacevic M, Rompen E, Lambert F (2015) Occurrence and risk indicators of medication-related osteonecrosis of the jaw after dental extraction: a systematic review and meta-analysis. J Clin Periodontol 42:922–932. https://doi.org/10.1111/jcpe.12455

Article  PubMed  Google Scholar 

Giovannacci I, Meleti M, Manfredi M, Mortellaro C, Greco LA, Bonanini M, Vescovi P (2016) Medication-related osteonecrosis of the jaw around dental implants. J Craniofac Surg. https://doi.org/10.1097/SCS.0000000000002564

Article  PubMed  Google Scholar 

Gkouveris I, Hadaya D, Soundia A, Bezouglaia O, Chau Y, Dry SM, Tetradis S (2019) Vasculature submucosal changes at early stages of osteonecrosis of the jaw (ONJ). Bone 123:234–45. https://doi.org/10.1016/j.bone.2019.03.031

Article  PubMed  PubMed Central  Google Scholar 

Granate-Marques A, Polis-Yanes C, Seminario-Amez M, Jane-Salas E, Lopez-Lopez J (2019) Medication-related osteonecrosis of the jaw associated with implant and regenerative treatments: systematic review. Medicina Oral Patología Oral y Cirugia Bucal 24(2):e195–e203. https://doi.org/10.4317/medoral.22691

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grbic JT, Black DM, Lyles KW, Reid DW, Orwoll E, McClung M, Bucci-Rechtweg C, Guoqin Su (2010) The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid data from the Health Outcomes and Reduced Incidence with Zoledronic Acid Once Yearly clinical trials program. J Am Dent Ass. 141(11):1365–1370. https://doi.org/10.14219/jada.archive.2010.0082

Hallmer F, Andersson G, Gotrick B et al (2018) Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw—a 4-year prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol 126:477

Hajishengallis G, Chavakis T (2021) Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol 21(7):426–440. https://doi.org/10.1038/s41577-020-00488-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hasegawa T, Kawakita A, Ueda N, Funahara R, Tachibana A, Kobayashi M, Kondou E, Takeda D, Kojima Y, Sato S, Yanamoto S, Komatsubara H, Umeda M, Kirita T, Kurita H, Shibuya Y, Komori T (2017) A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ? Osteoporos Int. 28(8):2465–2473. https://doi.org/10.1007/s00198-017-4063-7

Article  CAS  PubMed  Google Scholar 

Herrera D, Sanz M, Kebschull M, Jepsen S, Sculean A, Berglundh T, Kopp I (2022) Treatment of stage IV periodontitis: the EFP S3 level clinical practice guideline. J Clin Periodontol 49(S24):4–71. https://doi.org/10.1111/jcpe.13639

Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17(12):1726–1733. https://doi.org/10.1007/s00198-006-0172-4

Article  CAS  PubMed  Google Scholar 

Katsarelis H, Shah NP, Dhariwal DK, Pazianas M (2015) Infection and medication-related osteonecrosis of the jaw. J Dent Res 94(4):534–539. https://doi.org/10.1177/0022034515572021

Article  CAS  PubMed  Google Scholar 

Kendler DL, Cosman F, Stad RK, Ferrari S (2022) Denosumab in the treatment of osteoporosis: 10 years later: a narrative review. Adv Ther 39(1):58–74. https://doi.org/10.1007/s12325-021-01936-y

Article  PubMed  Google Scholar 

Kim AS, Girgis CM, McDonald MM (2022) Osteoclast recycling and the rebound phenomenon following denosumab discontinuation. Curr Osteoporos Rep 20(6):505–515. https://doi.org/10.1007/s11914-022-00756-5

Article  PubMed  PubMed Central